comparemela.com
Home
Live Updates
Akt Inhibitors - Breaking News
Pages:
Latest Breaking News On - Akt inhibitors - Page 1 : comparemela.com
HR+/HER2- Breast Cancer: Inhibiting the PI3K/AKT/mTOR Pathway
Dr Vidal expands on use of PI3K/AKT/mTOR pathway inhibitors following frontline progression, focusing on the PI3K inhibitor alpelisib for patients with PIK3CA mutations, as well as capivasertib, an AKT inhibitor in development.
Aditya bardia
Gregory vidal
Komal jhaveri
Hr her2 breast cancer
Cdk4 6 inhibitors
Second line therapies
Endocrine therapy
Endocrine resistance
Akt inhibitors
Capitello 291
Maintain trial
Ember 3
Oral serds
Viktoria 1
Innovation in cancer research showcased at Markey Research Day
A day-long spotlight event May 12 highlighted the latest advancements in cancer research underway at the University of Kentucky Markey Cancer Center.
United kingdom
Krystle kuhs
Kristen hill
Mark evers
Vilma bursac
Nan lin
Jing yan
Cullin neddylation
Christine brainson
Marvellae ford
Caitlin miller
Fengyi mao
Tianyan gao
Jessica thompson
Lois reynolds
Taylor rives
vimarsana © 2020. All Rights Reserved.